FORNEBU,Norway,Feb. 13,2025-- Aker Horizons ASA (OSE:AKH),a developer of green energy and industry,today announced results for the fourth quarter 2024. Aker Horizons\' net capital employed stood at NO
02-14
ASEAN Investment Challenge (AIC) 2024 brings together more than 5,000 higher education students for an insightful journey into responsible investing
02-14
SINGAPORE and RIYADH,Saudi Arabia,Feb. 13,2025-- SM C2R (Singapore),a member of Swan & Maclaren Group,and Advanced Lighting Company (ALC),a leading Saudi-based lighting manufacturer,proudly announ
02-14
The Only Forbes-Starred Hotel in Xiamen XIAMEN,China,Feb. 13,2025--Conrad Xiamen proudly announces its Four-Star recognition in the 2025 Forbes Travel Guide,making it the only hotel in Xiamen to recei
02-14
SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi
02-14
SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w
02-14
Digital media standards underlie every advance CAMBRIDGE,Mass.,Feb. 13,2025-- A new report byMIT Technology Review Insights explores how emerging tech is remaking the media and entertainment industri
02-14
CoE to provide leading 5G-6G capabilities for clients in telecommunications,smart factories,connected vehicles,and healthcare
02-14
VANCOUVER,BC,Feb. 13,2025-- IFS,the leading provider of enterprise cloud and Industrial AI software,announces that WEL Networks,a leading provider of innovative and sustainable energy solutions and el
02-14
PETALING JAYA,Malaysia,Feb. 14,2025-- As people live longer,ensuring a purposeful and fulfilling life becomes even more important.Life expectancy in Malaysia has steadily increased to 76.26 years ([1]
02-14
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
